KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Non-Current Deferred Tax Liability (2016 - 2025)

Pfizer (PFE) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 81.56% to $2.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 billion, a 81.56% decrease, with the full-year FY2025 number at $2.4 billion, down 81.56% from a year prior.
  • Non-Current Deferred Tax Liability was $2.4 billion for Q4 2025 at Pfizer, down from $2.5 billion in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $13.0 billion in Q4 2024 to a low of $328.0 million in Q4 2021.
  • A 5-year average of $3.0 billion and a median of $2.2 billion in 2024 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: crashed 93.28% in 2023, then soared 1934.84% in 2024.
  • Pfizer's Non-Current Deferred Tax Liability stood at $7.7 billion in 2021, then grew by 23.4% to $9.5 billion in 2022, then plummeted by 93.28% to $640.0 million in 2023, then skyrocketed by 1934.84% to $13.0 billion in 2024, then crashed by 81.56% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Non-Current Deferred Tax Liability are $2.4 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025).